NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
Voltar para busca
Dado oficial do USPTO
VORWARTS PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
17
Atualização mais recente
12/11/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
13/02/2024
Data de registro
11/11/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/11/2025
Última transação
12/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/02/2024
Primeiro uso no comércio
01/02/2024
Código do desenho
3
Tipo de titular
16
Localização do titular
Riga, LV
Examinador
KEAM,ALEX S
Unidade examinadora
O60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "VORWARTS PHARMA" written in stylized big black letters, where the letter "V" of the word "VORWARTS" is green and the letter "P" of the word "PHARMA" is grey, with the design of black line that is displayed under the verbal elements..
Titulares e representantes
Titulares
V. S. (pessoa física)
Representantes
Diana Portna
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Acai powder dietary supplements; Acaricides; Adjuvants for medical purposes; Albumin dietary supplements; Alginate dietary supplements; Amino acids for medical purposes; Anaesthetics; Analgesics; Anthelmintics; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antibiotics; Antiparasitic preparations; Antiseptics; Appetite suppressant pills; Bacterial preparations for medical and veterinary use; Bacteriological preparations for medical and veterinary use; Cardiovascular pharmaceuticals; Casein dietary supplements; Cellulose esters for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposesfor the treatment of erectile dysfunctionfor the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesfor the treatment of cardiovascular and cerebrovascular diseasesfor the treatment of anaphylactic reactions;; Dietary supplements with a cosmetic effect; Digestives for pharmaceutical purposes; Enzyme dietary supplements; Enzyme preparations for medical purposes; Ferments for pharmaceutical purposes; Food supplementsanti-oxidants; Glycerine for medical purposes; Haemoglobin; Herbal extractsother than essential oilsfor medical purposes; Infant formula; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for treatment of anaphylactic reactions; Lecithin dietary supplements; Medical preparations for slimming purposes; Medicated candies; Medicinal preparations for the treatment of erectile dysfunctionfor the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesfor the treatment of cardiovascular and cerebrovascular diseasesfor the treatment of anaphylactic reactions; Mineral dietary supplements; Nutraceuticals for the treatment of erectile dysfunctionocular disorders or diseasesbacteria-based diseasesdiabetescardiovascular and cerebrovascular diseasesanaphylactic reactions; Nutraceuticals for use as a dietary supplement; Nutritional supplements; Ocular pharmaceuticals; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of rectile dysfunctionocular disorders or diseasesbacteria-based diseasesdiabetescardiovascular and cerebrovascular diseasesanaphylactic reactions; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticalsanti-infectives; Pharmaceuticalsantihelmintics; Pharmaceuticalsinducers of erections; Pharmaceuticalslipid lowering agents; Pharmaceuticalspsychotropics; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Propolis dietary supplements; Propolis for pharmaceutical purposes; Protein dietary supplements; Vaginal washes for medical purposes; Vermifuges; Vitamin preparations; Wheat germ dietary supplements; Yeast dietary supplements; Yeast for pharmaceutical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
17 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21/10/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21/10/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
18/10/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
18/10/2025
IUAF
USE AMENDMENT FILED
15/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
15/05/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2024
PUBO
PUBLISHED FOR OPPOSITION
12/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2024
DOCK
ASSIGNED TO EXAMINER
02/10/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
25/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/06/2024
NWAP
NEW APPLICATION ENTERED
13/02/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VORWARTS PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.